%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png){kind=logo}
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 监事会决议公告 | 2025-08-07 | Chinese | |
| 投资者关系管理制度（2025年8月） | 2025-08-07 | Chinese | |
| 薪酬与考核委员会工作制度（2025年8月） | 2025-08-07 | Chinese | |
| 内幕信息知情人登记管理制度（2025年8月） | 2025-08-07 | Chinese | |
| 利润分配管理制度（2025年8月） | 2025-08-07 | Chinese | |
| 关于2025年上半年计提资产减值准备的公告 | 2025-08-07 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 40024283 | 监事会决议公告 | 2025-08-07 | Chinese | ||
| 40024277 | 投资者关系管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024267 | 薪酬与考核委员会工作制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024255 | 内幕信息知情人登记管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024239 | 利润分配管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024229 | 关于2025年上半年计提资产减值准备的公告 | 2025-08-07 | Chinese | ||
| 40024220 | 审计委员会工作制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024209 | 战略与ESG委员会工作制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024196 | 信息披露管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024189 | 募集资金管理制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024180 | 提名委员会工作制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024173 | 关于召开公司2025年第一次临时股东大会的通知 | 2025-08-07 | Chinese | ||
| 40024161 | 年报信息披露重大差错责任追究制度（2025年8月） | 2025-08-07 | Chinese | ||
| 40024151 | 2025年半年度募集资金存放与使用情况的专项报告 | 2025-08-07 | Chinese | ||
| 40024133 | 董事、高级管理人员离职管理制度（2025年8月） | 2025-08-07 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.